Bioethics LTD 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

OTC.Pink

25 Sept 2024

BOTH

Bioethics LTD

8-K: Bioethics, Ltd. to Acquire SILQ Technologies Corporation in Reverse Triangular Merger

Bioethics, Ltd. will acquire SILQ Technologies Corporation through a reverse triangular merger, with SILQ becoming a wholly-owned subsidiary.

OTC.Pink

26 Jun 2024

BOTH

Bioethics LTD

8-K: Bioethics Ltd. to Acquire SILQ Technologies in Reverse Triangular Merger

Bioethics Ltd. and SILQ Technologies have signed a non-binding letter of intent for Bioethics to acquire SILQ in a reverse triangular merger, with SILQ becoming a wholly-owned subsidiary.

OTC.Pink

30 Apr 2024

BOTH

Bioethics LTD

8-K: Bioethics, Ltd. Appoints Doug Morris to Board of Directors and Vice President of Corporate Development

Bioethics, Ltd. has appointed Doug Morris to its Board of Directors and as Vice President of Corporate Development, effective April 26, 2024.